
    
      Primary Outcome Measures:

      • Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events

      Secondary Outcome Measures:

      • Ventricular function,NYHA functional Class, 6 min walking test, biochemical test and Renal
      function as measured by Glomerular Filtration Rate (GFR)

      Eligibility Patients population: Volunteers, NYHA Class III-IV heart failure patients. Ages
      Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy
      Volunteers: No
    
  